Postgraduate medical journal
Pan-immune-inflammation value and systemic immune-inflammation index predict the clinical efficacy of biological agents in Crohn's disease.
Bin Liu, Daoli Liu, Chongbin Qi, Caroline Sunggip
Published: 202510.1093/postmj/qgaf172
Abstract
BACKGROUND: It remains unclear whether pan-immune-inflammation value (PIV) and systemic immune-inflammation index (SII) can predict treatment outcomes in Crohn's disease (CD) patients receiving infliximab. This study explored the role of PIV and SII…
Preview only. Read the full abstract at the source